1. OAR@UM
  2. Faculty of Medicine and Surgery
  3. Department of Pharmacy
  4. Scholarly Works - FacM&SPha
Please use this identifier to cite or link to this item: https://www.um.edu.mt/library/oar/handle/123456789/49976
Full metadata record
DC FieldValueLanguage
dc.date.accessioned2020-01-06T06:40:19Z-
dc.date.available2020-01-06T06:40:19Z-
dc.date.issued2016-03-
dc.identifier.citationWirth, F., Xuereb, R. G., Fenech, A., & Azzopardi, L. M. (2016, March). Pharmacist-led rapid point-of-care CYP2C19 genotyping for individualisation of antiplatelet therapy. Poster session presented at the 21st Congress of the European Association of Hospital Pharmacists, Vienna, Austria.en_GB
dc.identifier.urihttps://www.um.edu.mt/library/oar/handle/123456789/49976-
dc.description.abstractA poster presentation regarding pharmacist-led rapid point-of-care CYP2C19 genotyping for individualisation of antiplatelet therapy. Background: Presence of the CYP2C19 loss-of-function (LoF) *2 allele is associated with reduced antiplatelet effect in clopidogrel-treated patients. Since about 50% of major adverse cardiac events occur within the first few days after percutaneous coronary intervention (PCI), a rapid CYP2C19*2 genotype result is important to individualise antiplatelet therapy at the start of treatment. Objective: To apply a pharmacist-led process to individualise antiplatelet therapy guided by CYP2C19*2 genotype using the novel rapid point-of-care (POC) genetic testing system in patients undergoing PCI.en_GB
dc.language.isoenen_GB
dc.publisherUniversity of Malta. Department of Pharmacyen_GB
dc.rightsinfo:eu-repo/semantics/openAccessen_GB
dc.subjectBlood platelet disordersen_GB
dc.subjectBlood platelets -- Aggregationen_GB
dc.subjectClopidogrelen_GB
dc.subjectCoronary arteries -- Stenosisen_GB
dc.subjectPoint-of-care testingen_GB
dc.subjectCytochrome P-450 CYP2C19en_GB
dc.subjectPharmacists -- Practiceen_GB
dc.titlePharmacist-led rapid point-of-care CYP2C19 genotyping for individualisation of antiplatelet therapyen_GB
dc.typepresentationen_GB
dc.rights.holderThe copyright of this work belongs to the author(s)/publisher. The rights of this work are as defined by the appropriate Copyright Legislation or as modified by any successive legislation. Users may access this work and can make use of the information contained in accordance with the Copyright Legislation provided that the author must be properly acknowledged. Further distribution or reproduction in any format is prohibited without the prior permission of the copyright holder.en_GB
dc.description.reviewedN/Aen_GB
dc.contributor.creatorWirth, Francesca-
dc.contributor.creatorXuereb, Robert G.-
dc.contributor.creatorFenech, Albert-
dc.contributor.creatorAzzopardi, Lilian M.-
Appears in Collections:Scholarly Works - FacM&SPha

Files in This Item:
File Description SizeFormat 
Pharmacist_led_rapid_point_of_care_CYP2C19_genotyping_for_individualisation_of_antiplatelet_therapy_2016.pdf383.35 kBAdobe PDFView/Open
Show simple item record Statistics


Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.